Generic name |
mepolizumab | |
Strength |
100 mg/mL | |
Form |
lyophilized powder for subcutaneous injection |
Special Authority criteria |
Approval period |
---|---|
Initial For the add-on maintenance treatment of adult patients with severe eosinophilic asthma meeting ALL the following criteria:
OR
|
1 year |
First renewal Renewal of coverage requested by a respirologist or allergist with expertise in treating asthma will be considered for adult patients whose:
AND
OR
|
1 year |
Second and subsequent renewal Renewal of coverage requested by a respirologist or allergist with expertise in treating asthma will be considered for adult patients whose:
AND
OR
|
1 year |